CDH1 and gastric cancer: Studies have shown that somatic mutations and epigenetic alterations, such as promoter methylation of CDH1, are prevalent in sporadic cases of gastric cancer, particularly in the diffuse type, where they are associated with poor clinical outcomes [27,28].